Wockhardt will deepen its novel antibiotics pipeline over the next five years and focus on building a biosimilar business for ...

Pfizer's top-selling product last year was Eliquis, which it co-markets with Bristol Myers Squibb. The blood thinner ...

Bristol-Myers Squibb (NYSE:BMY – Get Free Report) was the target of a significant growth in short interest during the month ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Exxon Mobil Corp. (XOM), ...

A little over a year after winning manufacturing certification for its cell therapy factory-in-a-box, South San Francisco’s ...

Discover March 2025’s top biotech deals, featuring major collaborations in small molecules, bispecific antibodies and protein ...

Across the study, two patients experienced “serious adverse events of atrial fibrillation (AF) requiring cardioversion,” ...

Summary of Changes - In the fall of 2024, several pharmaceutical companies – specifically, Eli Lilly and Company, Sanofi-Aventis U.S. LLC, ...

Shares of Bristol Myers Squibb Co. BMY shed 2.36% to $59.55 Tuesday, on what proved to be an all-around mixed trading session ...

A federal appeals court on Tuesday affirmed the dismissal of a dental surgeon’s suit alleging Bristol-Myers Squibb Co.'s leukemia drug Sprycel caused retinal bleeding and vision loss.

Learn more about whether Bristol-Myers Squibb Company or Jazz Pharmaceuticals plc is a better investment based on AAII's A+ ...